Mepolizumab for allergic bronchopulmonary aspergillosis: Report of 20 cases from the Belgian Severe Asthma Registry and review of the literature

Affiliations

• ¹ Department of Respiratory Medicine, CHU Sart-Tilman Liege, University of Liege, Liege, Belgium. Electronic address: fschleich@chuliege.be.
• ² Clinical Immunoallergology, CHU Brugmann, ULB, Brussels, Belgium.
• ³ Laboratory of Allergy & Mucosal Immunology and Cliniques Universitaires St-Luc, Université catholique de Louvain (UCL), Brussels, Belgium.
• ⁴ Department of Respiratory Medicine, CHU of Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium.
• ⁵ Department of Respiratory Medicine, centre hospitalier EpiCURA, Site de Baudour, Belgium.
• ⁶ Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
• ⁷ Department of Respiratory Medicine, CHU-Charleroi, A.Vésale Hospital, Charleroi, Belgium.
• ⁸ Department of Respiratory Medicine, Universitair Ziekenhuis, Brussels, Belgium.
• ⁹ Department of Respiratory Medicine, CHU Sart-Tilman Liege, University of Liege, Liege, Belgium.